Baker Bros. Advisors Lp Genomic Health Inc (GHDX) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded
Dec 06 2018	SELL Open market or private sale	$6,993,557 $75.46 p/Share	92,679
Dec 04 2018	SELL Open market or private sale	$2,495,237 $76.13 p/Share	32,776
Dec 03 2018	SELL Open market or private sale	$15,780,601 $78.07 p/Share	202,134
Nov 30 2018	SELL Open market or private sale	$16,247,468 $79.35 p/Share	204,757
Nov 29 2018	SELL Open market or private sale	$4,010,452 $78.21 p/Share	51,278
Nov 28 2018	SELL Open market or private sale	$18,829,478 $75.2 p/Share	250,392
Nov 27 2018	SELL Open market or private sale	$10,257,140 $74.0 p/Share	138,610
Nov 26 2018	SELL Open market or private sale	$2,944,282 $74.21 p/Share	39,675
Nov 16 2018	SELL Open market or private sale	$6,730,289 $77.01 p/Share	87,395
Nov 13 2018	SELL Open market or private sale	$9,161,074 $79.76 p/Share	114,858
Nov 13 2018	SELL Open market or private sale	$11,051,185 $79.67 p/Share	138,712
Nov 12 2018	SELL Open market or private sale	$5,302,134 $80.84 p/Share	65,588
Nov 12 2018	SELL Open market or private sale	$1,158,678 $80.38 p/Share	14,415
Nov 09 2018	SELL Open market or private sale	$9,021,980 $83.74 p/Share	107,738
Nov 09 2018	SELL Open market or private sale	$14,096,194 $83.24 p/Share	169,344
Nov 08 2018	SELL Open market or private sale	$6,281,531 $86.35 p/Share	72,745
Nov 08 2018	SELL Open market or private sale	$6,543,461 $85.79 p/Share	76,273
Oct 01 2018	BUY Grant, award, or other acquisition	$119,587 $70.18 p/Share	1,704
Jul 01 2018	BUY Grant, award, or other acquisition	$119,750 $50.4 p/Share	2,376
Apr 01 2018	BUY Grant, award, or other acquisition	$119,778 $31.29 p/Share	3,828
Mar 09 2018	BUY Exercise of conversion of derivative security	$915,750 $18.5 p/Share	49,500
Jan 01 2018	BUY Grant, award, or other acquisition	$119,837 $34.2 p/Share	3,504
Oct 01 2017	BUY Grant, award, or other acquisition	$119,760 $32.09 p/Share	3,732

Also insider at

INCY

INCYTE CORP Healthcare

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

BLCM

BELLICUM PHARMACEUTICALS, INC Healthcare

> 10% Shareholder

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

KOD

Kodiak Sciences Inc. Healthcare

HOOK

HOOKIPA Pharma Inc. Healthcare

BCEL

Atreca, Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

BCYC

BICYCLE THERAPEUTICS plc Healthcare

IMCR

Immunocore Holdings plc Healthcare

KALA

Kala Pharmaceuticals, Inc. Healthcare

BBA